https://medlineplus.gov/druginfo/meds/a625067.html
Vimseltinib: MedlinePlus Drug Information
Vimseltinib: learn about side effects, dosage, special precautions, and more on MedlinePlus
vimseltinibmedlineplusdruginformation
https://www.mskcc.org/news/fda-approves-vimseltinib-for-tenosynovial-giant-cell-tumor-tgct
FDA Approves Vimseltinib for Tenosynovial Giant Cell Tumor (TGCT) | Memorial Sloan Kettering Cancer...
The U.S. Food and Drug Administration has approved vimseltinib for adult patients with a rare condition called tenosynovial giant cell tumor, based on a trial...
tenosynovial giant cell tumor
https://www.cigna.com/knowledge-center/hw/medications/vimseltinib-a625067
Vimseltinib | Cigna
Vimseltinib is used to treat tenosynovial giant cell tumors (tumor in or around a joint that can cause pain and reduce movement). Vimseltinib is in a class of...
vimseltinibcigna
https://www.cancer.gov/about-cancer/treatment/drugs/vimseltinib-dihydrate
Vimseltinib Dihydrate - NCI
This page contains brief information about vimseltinib dihydrate and a collection of links to more information about the use of this drug, research results,...
vimseltinibdihydratenci